APA (7th ed.) Citation

Lin, H., Sjaarda, J., Dyck, J., Stringer, R., Hillis, C., Harvey, M., . . . Sadikovic, B. (2016). Gender and BCR-ABL transcript type are correlated with molecular response to imatinib treatment in patients with chronic myeloid leukemia. European Journal of Haematology, 96(4), 360. https://doi.org/10.1111/ejh.12597

Chicago Style (17th ed.) Citation

Lin, Han‐Xin, et al. "Gender and BCR-ABL Transcript Type Are Correlated with Molecular Response to Imatinib Treatment in Patients with Chronic Myeloid Leukemia." European Journal of Haematology 96, no. 4 (2016): 360. https://doi.org/10.1111/ejh.12597.

MLA (9th ed.) Citation

Lin, Han‐Xin, et al. "Gender and BCR-ABL Transcript Type Are Correlated with Molecular Response to Imatinib Treatment in Patients with Chronic Myeloid Leukemia." European Journal of Haematology, vol. 96, no. 4, 2016, p. 360, https://doi.org/10.1111/ejh.12597.